Blood and bone marrow cancer treatment developer Priothera Limited has picked up a €30m Series A investment round from a clutch of venture capital firms.
Blood and bone marrow cancer treatment developer Priothera Limited has picked up a €30m Series A investment round from a clutch of venture capital firms.